Following fields are empty!

1
Search
2
Select
3
Submit
33
Journals
Go to Previous Page
Page 2 of 2

Request Journal

Please fill in the form to request a new journal to be added. We will review your request and add it to the Journal Guide as soon as possible.

*

Neuropsychiatric Disease and Treatment

ISSN: 1176-6328eISSN: 1178-2021
DOAJ Logo
SIGAPS Level C
Publisher: Dove Press
Visit Publisher homepageVisit journal homepage
Clinical NeurologyPsychiatry and Mental healthBiological Psychiatry
Loading data ...
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Go to Journal

Neuropsychobiology

ISSN: 0302-282XeISSN: 1423-0224
SIGAPS Level C
Publisher: Karger Publishers
Visit Publisher homepageVisit journal homepageView author guidelines
Psychiatry and Mental healthBiological PsychiatryPsychology(all)Neuropsychology and Physiological Psychology

The biological approach to mental disorders continues to yield innovative findings of clinical importance, particularly if methodologies are combined. This journal collects high-quality empirical studies from various experimental and clinical approaches in the fields of biological psychiatry, biological psychology, and neuropsychology. It features original, clinical, and basic research in the fields of neurophysiology and functional imaging, neuropharmacology and neurochemistry, neuroendocrinology and neuroimmunology, genetics, and their relationships with normal psychology and psychopathology. In addition, coverage includes studies on animal models of mental disorders and therapeutic interventions, and pharmacoelectroencephalographic studies, as well as reviews on new methodological approaches.

Read more
Loading data ...
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

List Price

CHF 3,600.00
EUR 3,750.00
USD 3,950.00

List Price

CHF 3,600.00
EUR 3,750.00
USD 3,950.00
Go to Journal

Pharmacology Biochemistry and Behavior

ISSN: 0091-3057eISSN: 1873-5177
SIGAPS Level B
Publisher: Elsevier
Visit Publisher homepageVisit journal homepage
BiochemistryClinical BiochemistryBehavioral NeuroscienceBiological PsychiatryPharmacologyToxicology

Pharmacology Biochemistry & Behavior publishes original reports in the areas of pharmacology and biochemistry in which the primary emphasis and theoretical context are behavioral. Contributions may involve clinical, preclinical, or basic research. Purely behavioral studies and toxicology studies will not be published unless they have directly demonstrable relevance to the areas of pharmacology or biochemistry. Papers describing the behavioral effects of novel psychoactive drugs in models of psychiatric diseases must include a positive control.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Read more
Loading data ...
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

Tous les auteurs correspondants des Hospices Civils de Lyon ont la possibilité de publier leurs articles de recherches en Open Access dans cette revue. Pour bénéficier de cette prise en charge, déclarez les "Hospices Civils de Lyon" dans votre affiliation principale et utilisez votre adresse mail "@chu-lyon.fr" lors de la soumission de votre article.

ATTENTION:

  • Si l'éditeur vous demande de sélectionner la licence applicable, privilégiez la licence CC-BY à toutes autres.
  • Pour les revues non éligibles, dont The Lancet et les revues Cell Press, ou en cas d’épuisement du stock de droits, la publication en accès ouvert immédiat devient payante mais de manière optionnelle ; le tarif bénéficie dans ce cas d’une remise de 10%.
  • Les articles publiés en accès ouvert immédiat au titre de l’accord peuvent être déposés dans leur version finale éditeur dans une archive ouverte, par exemple dans HAL-HCL.
  • Dans le cas des articles sous abonnement, il est permis par la Loi République numérique de déposer dans une archive ouverte le manuscrit auteur accepté d’un article et de le diffuser avec un embargo de 6 mois (sciences dures) ou 12 mois (SHS).

Si vous rencontrez des difficultés ou si vous avez des questions, contactez la Documentation Centrale sur sa.documentationcentrale@chu-lyon.fr ou au 04-72-11-29-99 (31-29-99)